Key result
Higher non-contrast PCAT attenuation linked to ~4% greater coronary microcalcification activity per HU in diabetes.
Why the study?
Coronary microcalcification activity independently prognosticates cardiovascular disease risk, but its relationship with dysfunctional peri-coronary adipose tissue has not been characterised in people with diabetes mellitus.
Is peri-coronary inflammation (measured by NC-PCAT) associated with coronary microcalcification activity in subjects with diabetes mellitus?
Is peri-coronary inflammation (measured by NC-PCAT) associated with coronary microcalcification activity in subjects with diabetes mellitus?
In patients with diabetes mellitus, elevated non-contrast peri-coronary adipose tissue attenuation is independently associated with greater coronary microcalcification activity, suggesting a link between local inflammation and microcalcification.
Hypothesis-generating for peri-coronary inflammation in diabetic coronary microcalcification; prospective studies needed before clinical adoption.
Coronary microcalcification activity (CMA) independently prognosticates cardiovascular disease risk. The relationship between dysfunctional peri-coronary adipose tissue (PCAT), a measure of local inflammation, and CMA has not been characterised in people with diabetes mellitus. Subjects with diabetes mellitus underwent 18F-Sodium Fluoride (18F-NaF) Positron Emission Tomography (PET) imaging and Computed Tomography (CT) coronary calcium score (CCS) imaging. Non-contrast PCAT (NC-PCAT) was quantified using the CT-value (Hounsfield Units (HU)) of the tissue adjacent to the right coronary artery. In total, 151 subjects were studied (mean age 65.4 ± 6.9, male 65.6%). Male sex (OR 2.44, 95% CI [1.17–5.05], p = 0.017 ), statin use (2.75 [1.09–6.89], p = 0.031 ), any oral antihyperglycemic use (0.43 [0.19–0.97], p = 0.043 ), eGFR (1.03 [1.00–1.05], p = 0.037 ) and the CT CCS (per 100 Agatston units, 1.17 [1.08–1.27], p < 0.001 ) were associated with increasing CMA. Furthermore, the NC-PCAT (per 1 HU) was positively and independently associated with increasing CMA (1.04 [1.01–1.07], p = 0.022 ). An NC-PCAT higher than −68.3 ( N = 21) was specific for triple-vessel CMA (specificity 90%, sensitivity 47%). An elevated NC-PCAT value is independently associated with a greater CMA in people with diabetes mellitus. Further research is required to determine if NC-PCAT measures provide CVD risk stratification beyond the CT CCS. • 18F-NaF PET provides unique molecular insights into pathophysiological drivers coronary microcalcification activity in people with diabetes • PCAT can be reliably measured on non-contrast studies, and associates with measures of cardiometabolic disease • Higher NC-PCAT values associate with increased CMA burden in people with diabetes mellitus • NC-PCAT assessment may provide useful risk stratification information above the CT CCS in people with diabetes, although further research is needed.
No takes yet. Share an insight, caveat, or question.
Smith et al. (2026) studied this question. Non-contrast peri-coronary adipose tissue was independently associated with increasing coronary microcalcification activity (OR 1.04 per 1 HU) in subjects with diabetes mellitus.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: